Literature DB >> 12587071

Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model.

R Firouzi1, A Rolland, M Michel, E Jouvin-Marche, J J Hauw, C Malcus-Vocanson, F Lazarini, L Gebuhrer, J M Seigneurin, J L Touraine, K Sanhadji, P N Marche, H Perron.   

Abstract

A retroviral element (multiple sclerosis-associated retrovirus, MSRV) defining a family of genetically inherited endogenous retroviruses (human endogenous retrovirus type W, HERV-W) has been characterized in cell cultures from patients with multiple sclerosis. Recently, MSRV retroviral particles or the envelope recombinant protein were shown to display superantigen activity in vitro, but no animal model has yet been set up for studying the pathogenicity of this retrovirus. In the present study, the pathogenicity of different sources of MSRV retroviral particles has been evaluated in a hybrid animal model: severe combined immunodeficiency (SCID) mice grafted with human lymphocytes and injected intraperitoneally with MSRV virion or mock controls. MSRV-injected mice presented with acute neurological symptoms and died within 5 to 10 days post injection. Necropsy revealed disseminated and major brain hemorrhages, whereas control animals did not show abnormalities (P <.001). In ill animals, reverse transcriptase-polymerase chain reaction (RT-PCR) analyses showed circulating MSRV RNA in serum, whereas overexpression of proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma was evidenced in spleen RNA. Neuropathological examination confirmed that hemorrhages occurred prior to death in multifocal areas of brain parenchyma and meninges. Further series addressed the question of immune-mediated pathogenicity, by inoculating virion to SCID mice grafted with total and T lymphocyte-depleted cells in parallel: dramatic and statistically significant reduction in the number of affected mice was observed in T-depleted series (P <.001). This in vivo study suggests that MSRV retroviral particles from MS cultures have potent immunopathogenic properties mediated by T cells compatible with the previously reported superantigen activity in vitro, which appear to be mediated by an overexpression of proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587071     DOI: 10.1080/13550280390173328

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  64 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Retroviral RNA related to ERV9/MSRV in a human serum: a new sequence variant.

Authors:  P Olsson; B Ryberg; R Awad; S Ammoun; H Yin; S Hjalmarsson; J Blomberg
Journal:  AIDS Res Hum Retroviruses       Date:  1999-04-10       Impact factor: 2.205

3.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Authors:  J A Garson; P W Tuke; P Giraud; G Paranhos-Baccala; H Perron
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 5.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

6.  Molecular cloning and phylogenetic analysis of new human endogenous retrovirus HERV-W family in cancer cells.

Authors:  Joo-Mi Yi; Hwan-Mook Kim; Won-Ho Lee; Heui-Soo Kim
Journal:  Curr Microbiol       Date:  2002-03       Impact factor: 2.188

7.  Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia.

Authors:  C Serra; S Sotgiu; G Mameli; M Pugliatti; G Rosati; A Dolei
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

Review 8.  The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions.

Authors:  P Marrack; G M Winslow; Y Choi; M Scherer; A Pullen; J White; J W Kappler
Journal:  Immunol Rev       Date:  1993-02       Impact factor: 12.988

Review 9.  T-cell repertoire diversity and clonal expansions in normal and clinical samples.

Authors:  C Pannetier; J Even; P Kourilsky
Journal:  Immunol Today       Date:  1995-04

10.  Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells.

Authors:  R Sun; E Grogan; D Shedd; A F Bykovsky; V M Kushnaryov; S E Grossberg; G Miller
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

View more
  36 in total

1.  Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Authors:  Magdalena Janina Laska; Tomasz Brudek; Kari Konstantin Nissen; Tove Christensen; Anné Møller-Larsen; Thor Petersen; Bjørn Andersen Nexø
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus.

Authors:  Antonina Dolei
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis.

Authors:  Renée Douville; Jiankai Liu; Jeffrey Rothstein; Avindra Nath
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 4.  An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

5.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 6.  Allergic fungal sinusitis.

Authors:  Mark S Schubert
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

7.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

8.  Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.

Authors:  François Curtin; Hervé Perron; Raphael Faucard; Hervé Porchet; Alois B Lang
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

Review 9.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

10.  Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

Authors:  Klemens Ruprecht; Felix Gronen; Marlies Sauter; Barbara Best; Peter Rieckmann; Nikolaus Mueller-Lantzsch
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.